These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6149278)

  • 1. The effect of sinusoidal vibration on the uniformity of packing of powder beds.
    Woodhead PJ; Newton JM
    J Pharm Pharmacol; 1984 Sep; 36(9):573-7. PubMed ID: 6149278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of deposition method on the packing uniformity of powder beds.
    Woodhead PJ; Newton JM
    J Pharm Pharmacol; 1983 Mar; 35(3):133-7. PubMed ID: 6132967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vibratory consolidation of particle size fractions of powders.
    Woodhead PJ; Chapman SR; Newton JM
    J Pharm Pharmacol; 1983 Oct; 35(10):621-6. PubMed ID: 6139429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segregation of vibrated powder mixes containing different concentrations of fine potassium chloride and tablet excipients.
    Staniforth JN; Rees JE
    J Pharm Pharmacol; 1983 Sep; 35(9):549-54. PubMed ID: 6138402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between sine random vibrations, resonance and drug content uniformity.
    Staniforth JN
    J Pharm Pharmacol; 1984 Apr; 36(4):258-60. PubMed ID: 6144775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vibration time, frequency and acceleration on drug content uniformity.
    Staniforth JN; Rees JE
    J Pharm Pharmacol; 1982 Nov; 34(11):700-6. PubMed ID: 6129298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of porosity variations in powder beds.
    Woodhead PJ; Hardy JG; Newton JM
    J Pharm Pharmacol; 1982 Jun; 34(6):352-8. PubMed ID: 6124616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The development and evaluation of technology of hard capsules filling with powder mixtures].
    Draksiene G; Paulauskaite G; Savickas A
    Medicina (Kaunas); 2006; 42(7):592-9. PubMed ID: 16861843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of components in the different size fractions of granules prepared from binary mixtures.
    Opakunle WO; Spring MS
    J Pharm Pharmacol; 1977 May; 29(5):298-302. PubMed ID: 17695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of a low-dose capsule filling process by dynamic and static tests for advanced process understanding.
    Stranzinger S; Faulhammer E; Scheibelhofer O; Calzolari V; Biserni S; Paudel A; Khinast JG
    Int J Pharm; 2018 Apr; 540(1-2):22-30. PubMed ID: 29407875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between particle packing and the physical stability of powder mixes.
    Staniforth JN
    J Pharm Pharmacol; 1985 Oct; 37(10):692-7. PubMed ID: 2867136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating.
    Zhou Q; Armstrong B; Larson I; Stewart PJ; Morton DA
    J Pharm Sci; 2010 Feb; 99(2):969-81. PubMed ID: 19795479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
    Sethuraman VV; Hickey AJ
    AAPS PharmSciTech; 2002; 3(4):E28. PubMed ID: 12916922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the effects of high shear blending on lactose and drug using fluidised bed elutriation.
    Willetts JP; Robbins PT; Roche TC; Bowley M; Bridson RH
    Int J Pharm; 2012 Sep; 434(1-2):272-9. PubMed ID: 22683647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roller compaction: Effect of morphology and amorphous content of lactose powder on product quality.
    Omar CS; Dhenge RM; Osborne JD; Althaus TO; Palzer S; Hounslow MJ; Salman AD
    Int J Pharm; 2015 Dec; 496(1):63-74. PubMed ID: 26117279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
    Xu Z; Mansour HM; Mulder T; McLean R; Langridge J; Hickey AJ
    J Pharm Sci; 2010 Aug; 99(8):3398-414. PubMed ID: 20198688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
    Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blending of agglomerates into powders 1: Quantification of abrasion rate.
    Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K
    Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.